USFDA declines to approve Merck chronic cough drug Gefapixant Ruchika Sharma21 Dec 2023 11:30 AM ISTNew Jersey: The U.S. Food and Drug Administration (FDA) declined to approve Merck's drug for chronic cough, the company said on Wednesday,...
USFDA staff flags concerns about Merck chronic cough drug Ruchika Sharma16 Nov 2023 1:25 PM ISTStaff assessment of the data submitted by Merck showed a small reduction in cough frequency and side effects such as loss of taste in patients who...
Gefapixant Effective treatment option for Chronic Cough Dr. Kamal Kant Kohli19 Sept 2023 10:00 AM ISTChronic cough can be a challenging condition to manage, especially when it doesn't respond to conventional treatments. In the search for new...
Gefapixant effective treatment for unexplained chronic cough: Lancet Medical Dialogues Editorial Team13 April 2022 10:15 AM ISTA phase 3 clinical study conducted by Prof Lorcan P McGarvey and team has revealed that for refractory chronic cough or unexplained chronic cough,...
No USFDA approval for Merck cough drug Gefapixant Ruchika Sharma25 Jan 2022 12:47 PM ISTNew Delhi: Merck & Co said on Monday the U.S. Food and Drug Administration declined to approve its experimental drug for the treatment...
Gefapixant significantly reduces Refractory Chronic cough frequency: Study Dr Satabdi Saha14 Sept 2020 6:00 PM ISTPatients with refractory chronic cough had significant reductions in coughing with lower doses of gefapixant than previously evaluated, demonstrating...
Gefapixant effective option for uncontrolled chronic cough, finds study Dr. K B Aarthi22 March 2020 6:45 PM ISTGefapixant controls chronic refractory cough by inhibiting P2X3 receptors that are associated with neuronal hypersensitization in the airways and...
New drug Gefapixant effectively relieves chronic cough: Lancet Dr. Kamal Kant Kohli26 Feb 2020 7:00 PM ISTResearchers have found a new drug that can ease the often distressing symptoms of chronic cough at low doses with minimal side effects. The new...
